New findings from Spherix Global Insights’ Patient Chart Dynamix™: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as specialists increasingly incorporate biologics, ...

March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...

A new study examined whether urinary biomarkers could predict future kidney complications in individuals with lupus nephritis ...

The MAJESTY global phase 3 study evaluating obinutuzumab (Gazyva) in primary membranous nephropathy (PMN) demonstrated ...

The use of existing guidelines for pediatric treatment varies significantly among sites, a new study has found. The study findingssuggest wide variation exists in the medications prescribed to treat ...

Initial uptake reflects strong efficacy-driven positioning relative to established therapies, though familiarity gaps, payer ...

Eventual tapering and withdrawal of steroids in patients with lupus nephritis is recommended to minimize the drugs' adverse effects, but the ideal timing is uncertain. This study followed 136 lupus ...

The case: A 57-year-old man presented to hospital with a 2-week history of progressive malaise, myalgia, fever, nausea, vomiting, diarrhea, polyuria and polydipsia. He had a history of gastresophageal ...

This transcript has been edited for clarity. Matthew A. Sparks, MD: I'm Dr Matthew Sparks, and welcome to Medscape's InDiscussion podcast series on chronic kidney disease. Today we'll be discussing ...

The systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM: the USA, France, ...

This page lists all known medications that could potentially lead to 'Nephritis' as a side effect. It's important to note that mild side effects are quite common with medications. The medication(s) ...